KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Non-Current Deffered Revenue: 2009-2019

Historic Non-Current Deffered Revenue for Rigel Pharmaceuticals (RIGL) over the last 11 years, with Dec 2019 value amounting to $1.4 million.

  • Rigel Pharmaceuticals' Non-Current Deffered Revenue fell 99.42% to $146,000 in Q3 2020 from the same period last year, while for Sep 2020 it was $146,000, marking a year-over-year decrease of 99.42%. This contributed to the annual value of $1.4 million for FY2019, which is 0.28% down from last year.
  • Rigel Pharmaceuticals' Non-Current Deffered Revenue amounted to $1.4 million in FY2019, which was down 0.28% from $1.4 million recorded in FY2018.
  • Over the past 5 years, Rigel Pharmaceuticals' Non-Current Deffered Revenue peaked at $3.1 million during FY2015, and registered a low of $90,000 during FY2017.
  • Moreover, its 3-year median value for Non-Current Deffered Revenue was $1.4 million (2019), whereas its average is $967,333.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Non-Current Deffered Revenue slumped by 90.95% in 2016 and then surged by 1,464.44% in 2018.
  • Rigel Pharmaceuticals' Non-Current Deffered Revenue (Yearly) stood at $3.1 million in 2015, then tumbled by 90.95% to $279,000 in 2016, then crashed by 67.74% to $90,000 in 2017, then soared by 1,464.44% to $1.4 million in 2018, then dropped by 0.28% to $1.4 million in 2019.